389 related articles for article (PubMed ID: 26172398)
21. Antigen presentation by hapten-specific B lymphocytes. III. Analysis of the immunoglobulin-dependent pathway of antigen presentation to interleukin 1-dependent T lymphocytes.
Rock KL; Haber SI; Liano D; Benacerraf B; Abbas AK
Eur J Immunol; 1986 Nov; 16(11):1407-12. PubMed ID: 2946591
[TBL] [Abstract][Full Text] [Related]
22. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
23. Immune pathomechanism and classification of drug hypersensitivity.
Pichler WJ
Allergy; 2019 Aug; 74(8):1457-1471. PubMed ID: 30843233
[TBL] [Abstract][Full Text] [Related]
24. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
Schmid DA; Depta JP; Lüthi M; Pichler WJ
Mol Pharmacol; 2006 Jul; 70(1):356-65. PubMed ID: 16617162
[TBL] [Abstract][Full Text] [Related]
25. Etiology and pathogenesis of adverse drug reactions.
Hausmann O; Schnyder B; Pichler WJ
Chem Immunol Allergy; 2012; 97():32-46. PubMed ID: 22613852
[TBL] [Abstract][Full Text] [Related]
26. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes.
Zanni MP; von Greyerz S; Schnyder B; Brander KA; Frutig K; Hari Y; Valitutti S; Pichler WJ
J Clin Invest; 1998 Oct; 102(8):1591-8. PubMed ID: 9788973
[TBL] [Abstract][Full Text] [Related]
27. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.
Illing PT; Vivian JP; Dudek NL; Kostenko L; Chen Z; Bharadwaj M; Miles JJ; Kjer-Nielsen L; Gras S; Williamson NA; Burrows SR; Purcell AW; Rossjohn J; McCluskey J
Nature; 2012 Jun; 486(7404):554-8. PubMed ID: 22722860
[TBL] [Abstract][Full Text] [Related]
28. Predictive drug allergy testing: an alternative viewpoint.
Pichler WJ
Toxicology; 2001 Feb; 158(1-2):31-41. PubMed ID: 11164990
[TBL] [Abstract][Full Text] [Related]
29. The importance of hapten-protein complex formation in the development of drug allergy.
Faulkner L; Meng X; Park BK; Naisbitt DJ
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):293-300. PubMed ID: 24936850
[TBL] [Abstract][Full Text] [Related]
30. [Pathogenic Mechanism and Diagnostic Testing for Drug Allergies].
Uno K
Yakugaku Zasshi; 2018; 138(2):151-167. PubMed ID: 29386429
[TBL] [Abstract][Full Text] [Related]
31. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Schmid DA; Depta JP; Pichler WJ
Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267
[TBL] [Abstract][Full Text] [Related]
32. Selective elimination of antigen-specific line T cells and ex vivo antigen-primed lymph node cells by antigen-targeted drug-labeled antigen-presenting cell membranes.
Chang NH; Boggs JM
Cell Immunol; 1997 Mar; 176(2):135-45. PubMed ID: 9073386
[TBL] [Abstract][Full Text] [Related]
33. Teleost T and NK cell immunity.
Fischer U; Koppang EO; Nakanishi T
Fish Shellfish Immunol; 2013 Aug; 35(2):197-206. PubMed ID: 23664867
[TBL] [Abstract][Full Text] [Related]
34. [Molecular basis for detection of infectious agents].
Siegrist CA
Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
[TBL] [Abstract][Full Text] [Related]
35. IgE antibodies to betalactams: relationship between the triggering hapten and the specificity of the immune response.
Antúnez C; Fernández T; Blanca-Lopez N; Torres MJ; Mayorga C; Canto G; Fernández J; Moya MC; Blanca M
Allergy; 2006 Aug; 61(8):940-6. PubMed ID: 16867046
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms leading to T-cell activation in drug hypersensitivity.
Meng X; Yerly D; Naisbitt DJ
Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):317-324. PubMed ID: 29905574
[TBL] [Abstract][Full Text] [Related]
37. Metal-protein complex-mediated transport and delivery of Ni2+ to TCR/MHC contact sites in nickel-specific human T cell activation.
Thierse HJ; Moulon C; Allespach Y; Zimmermann B; Doetze A; Kuppig S; Wild D; Herberg F; Weltzien HU
J Immunol; 2004 Feb; 172(3):1926-34. PubMed ID: 14734778
[TBL] [Abstract][Full Text] [Related]
38. Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors.
Abbas AK; Haber S; Rock KL
J Immunol; 1985 Sep; 135(3):1661-7. PubMed ID: 2410498
[TBL] [Abstract][Full Text] [Related]
39. MHC class II gene products specific autoreactive T cell clones provide inducer as well as amplifier function for B cell Ig production.
Bensussan A; Milanese C; Meuer SC; Reinherz EL
Behring Inst Mitt; 1985 Aug; (77):93-104. PubMed ID: 2417587
[TBL] [Abstract][Full Text] [Related]
40. Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions.
Gerber BO; Pichler WJ
AAPS J; 2006 Mar; 8(1):E160-5. PubMed ID: 16584124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
